Immunoassay analyzers are used to carry out various types of immunoassay testing for laboratory purposes. A fully automated immunoassay analyzer is a compact device with a built-in computer, keypad, and printer. The equipment finds great application in hospitals and clinical laboratories. Immunoassay-Analyzers designed with Advanced Features for Precise Results Siemens Medical Solutions Diagnostics, a new division of DPC and Bio Merieux, is a leading manufacturer of immunoassay analyzers. Some of the models they offer are: Immulite 2000: It has the capacity to perform 200 tests per hour. The unique features of this equipment are clot detection, primary tube sampling, proprietary onboard solution...

It is commonly asserted that in vitro diagnostics is a recession-proof industry. Kalorama Information's lead diagnostic analyst Shara Rosen tests that assumption and provides strategic conclusions in Shara Rosen's new report In Vitro Diagnostics in a Recession. The economic problems that began slowing the U.S. economy keep spreading, with Europe and Japan following America into recession. The US is experiencing high unemployment rate and increased numbers of uninsured workers. But what impact is the downturn having on in vitro diagnostic companies? What are the best areas of IVD and the best world markets? How should companies price and market their products? What are key companies in the market...

Immunoassay analyzers are immunodiagnostic systems to carry out different types of immunoassay tests in the clinical laboratory at a fast rate. Immunoassay analyzers for medium-size labs are provided with innovative features such as window based software, positive ample ID, remote diagnostics, on-board dilutions, and consolidated footprint.   Different Models of Immunoassay Analyzers with Vast Array of Features Immulite 1000, Immulite 2000, and Mini VIDAS are some of the modern immunoassay analyzers for medium-size labs. Immulite 1000 and Immulite 2000 are from Siemens Medical Solutions Diagnostics which is a new division of DPC (Diagnostic Products Corporation). DPC Immulite 1000: These models are...

Germany In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 Summary This report is an essential source for in-depth information and data relating to Germany In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Germany Scope - The report provides information on the German in vitro diagnostics market, broken down into detailed categories and segments such as In Vitro Diagnostics, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents...

in vitro diagnostics

Global In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 Summary This report is an essential source for key information and data relating to global in vitro diagnostics market. The report provides global and country level, detailed and comprehensive coverage of market and category revenue, distribution and company share information. It also provides company profiles, pipeline products, news and financial deals in the global in vitro diagnostics market. Scope - This report provides detailed data on country-wise market size in countries such as United States, Germany, United Kingdom, France, Italy, Spain, Japan, Canada, China, India, Australia, Brazil. - It provides data on...

Global In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 Summary This report is an essential source for key information and data relating to global in vitro diagnostics market. The report provides global and country level, detailed and comprehensive coverage of market and category revenue, distribution and company share information. It also provides company profiles, pipeline products, news and financial deals in the global in vitro diagnostics market. Scope - This report provides detailed data on country-wise market size in countries such as United States, Germany, United Kingdom, France, Italy, Spain, Japan, Canada, China, India, Australia, Brazil. - It provides data on...

vitro diagnostics

South and Central America In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 Summary This report is an essential source for in-depth information and data relating to South & Central America In vitro diagnostics market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in South & Central America. Scope The report provides information on the South and Central American in vitro diagnostics market, broken down into detailed categories and segments including In Vitro...

in vitro diagnostic

Make the most of limited resources by benchmarking IVDs' budgets and staff support for development, marketing, reimbursement and sales. To achieve commercial success, in vitro diagnostic (IVD) companies must earn the approval of several different groups. Regulators, payer organizations, healthcare providers and laboratory technicians ultimately determine the value of a product -- and how well it will do in the market. For that reason, strategic market-focused product development and effective commercialization are crucial. Slim margins and tight budgets, however, make it a formidable task to design and promote an IVD with a clear picture of the market. To help teams achieve success in their IVD...

"Molecular diagnostics or the analysis of DNA and RNA at the molecular level - is a fast-growing market, driven by the growing understanding of the human genome. Although a small part of the In-Vitro Diagnostics (IVD) market, molecular diagnostics market is one of the two growth drivers of the IVD industry. In the decision making process of healthcare experts, diagnostics tests have a major influence. Diagnostics tests are a very small percentage cost of medical expenditures but generally accounts for 60-70% of all treatment decisions. And with the advent of molecular diagnostics, there is a growing focus on diagnostics for early detection of diseases. Molecular diagnostics holds immense business...


1 2 3 4 5 6 7 8 9